Core Scientific's largest shareholder opposes the all-stock sale to CoreWeave, stating that the transaction undervalues the company.

BlockBeats News, August 8: Core Scientific's largest shareholder, Two Seas Capital, announced that it will vote against its sale to CoreWeave in an all-stock deal, stating that the transaction was undervalued and had serious structural flaws.

In July of this year, CoreWeave announced its acquisition of the digital infrastructure company Core Scientific in an all-stock deal. The agreed-upon per-share value of this transaction is $20.40. The agreed-upon exchange ratio implies a company valuation of around $9 billion.